Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients.
Latva-Rasku A, Honka MJ, Kullberg J, Mononen N, Lehtimäki T, Saltevo J, Kirjavainen AK, Saunavaara V, Iozzo P, Johansson L, Oscarsson J, Hannukainen JC, Nuutila P. Latva-Rasku A, et al. Among authors: lehtimaki t. Diabetes Care. 2019 May;42(5):931-937. doi: 10.2337/dc18-1569. Epub 2019 Mar 18. Diabetes Care. 2019. PMID: 30885955 Free article. Clinical Trial.
Coronary flow reserve is reduced in young men with IDDM.
Pitkänen OP, Nuutila P, Raitakari OT, Rönnemaa T, Koskinen PJ, Iida H, Lehtimäki TJ, Laine HK, Takala T, Viikari JS, Knuuti J. Pitkänen OP, et al. Among authors: lehtimaki tj. Diabetes. 1998 Feb;47(2):248-54. doi: 10.2337/diab.47.2.248. Diabetes. 1998. PMID: 9519721
Paraoxonase gene polymorphisms and coronary reactivity in young healthy men.
Malin R, Knuuti J, Janatuinen T, Laaksonen R, Vesalainen R, Nuutila P, Jokela H, Laakso J, Jaakkola O, Solakivi T, Lehtimäki T. Malin R, et al. Among authors: lehtimaki t. J Mol Med (Berl). 2001 Aug;79(8):449-58. doi: 10.1007/s001090100232. J Mol Med (Berl). 2001. PMID: 11511975
High oxidized LDL and elevated plasma homocysteine contribute to the early reduction of myocardial flow reserve in healthy adults.
Laaksonen R, Janatuinen T, Vesalainen R, Lehtimäki T, Elovaara I, Jaakkola O, Jokela H, Laakso J, Nuutila P, Punnonen K, Raitakari O, Saikku P, Salminen K, Knuuti J. Laaksonen R, et al. Among authors: lehtimaki t. Eur J Clin Invest. 2002 Nov;32(11):795-802. doi: 10.1046/j.1365-2362.2002.01051.x. Eur J Clin Invest. 2002. PMID: 12423319
Endothelial nitric oxide synthase genotype modulates the improvement of coronary blood flow by pravastatin: a placebo-controlled PET study.
Kunnas TA, Lehtimäki T, Laaksonen R, Ilveskoski E, Janatuinen T, Vesalainen R, Nuutila P, Karhunen PJ, Knuuti J, Nikkari ST. Kunnas TA, et al. Among authors: lehtimaki t. J Mol Med (Berl). 2002 Dec;80(12):802-7. doi: 10.1007/s00109-002-0398-3. Epub 2002 Nov 22. J Mol Med (Berl). 2002. PMID: 12483466 Clinical Trial.
Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.
Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Mattila K, Ilveskoski E, Luomala M, Saikku P, Knuuti J, Hurme M. Lehtimäki T, et al. Pharmacogenetics. 2003 Oct;13(10):633-9. doi: 10.1097/00008571-200310000-00007. Pharmacogenetics. 2003. PMID: 14515062 Clinical Trial.
1,313 results